Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2023 Financial Results on March 21, 2024
04 Março 2024 - 9:30AM
Business Wire
Apyx® Medical Corporation (NASDAQ:APYX) (the “Company”),
the manufacturer of a proprietary helium plasma and radiofrequency
technology marketed and sold as Renuvion®, today announced that
financial results for the fourth quarter and fiscal year 2023 will
be released before the market opens on Thursday, March 21st.
Management will host a conference call at 8:00 a.m. Eastern Time
on March 21st to discuss the results of the quarter and year, and
to host a question and answer session. To listen to the call by
phone, interested parties may dial 877-407-8289 (or 201-689-8341
for international callers) and provide access code 13744178.
Participants should ask for the Apyx Medical Corporation Call. A
live webcast of the call will be accessible via the Investor
Relations section of the Company’s website and at:
https://event.choruscall.com/mediaframe/webcast.html?webcastid=KtFzwD3M
A telephonic replay will be available approximately three hours
after the call ends through the following two weeks. The replay can
be accessed by dialing 877-660-6853 for U.S. callers or
201-612-7415 for international callers and using the replay access
code: 13744178. The webcast will be archived on the Investor
Relations section of the Company’s website.
About Apyx Medical
Corporation:
Apyx Medical Corporation is an advanced energy technology
company with a passion for elevating people’s lives through
innovative products, including its Helium Plasma Technology
products marketed and sold as Renuvion in the cosmetic surgery
market and J-Plasma® in the hospital surgical market. Renuvion and
J-Plasma offer surgeons a unique ability to provide controlled heat
to tissue to achieve their desired results. The Company also
leverages its deep expertise and decades of experience in unique
waveforms through OEM agreements with other medical device
manufacturers. For further information about the Company and its
products, please refer to the Apyx Medical Corporation website at
www.ApyxMedical.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240304730274/en/
Investor Relations: ICR
Westwicke on behalf of Apyx Medical Corporation Mike Piccinino, CFA
investor.relations@apyxmedical.com
Apyx Medical (NASDAQ:APYX)
Gráfico Histórico do Ativo
De Set 2024 até Out 2024
Apyx Medical (NASDAQ:APYX)
Gráfico Histórico do Ativo
De Out 2023 até Out 2024